Galactose and cataract.
Stambolian D.
Surv Ophthalmol. 1988 Mar-Apr;32(5):333-49. doi: 10.1016/0039-6257(88)90095-1.
Galactose cataract: a review.
Van Heyningen R.
Exp Eye Res. 1971 May;11(3):415-28. doi: 10.1016/s0014-4835(71)80054-4.
Characterization of an i.p. D-galactose-induced cataract model in rats.
Zhong L, Wang T, Wang T, Cheng H, Deng J, Ye H, Li W, Ling S.
J Pharmacol Toxicol Methods. 2021 Jan-Feb;107:106891. doi: 10.1016/j.vascn.2020.106891. Epub 2020 Jul 3.
Galactose and cataract.
Clemens PC.
Surv Ophthalmol. 1989 May-Jun;33(6):528. doi: 10.1016/0039-6257(89)90055-6.
Esculetin and idebenone ameliorate galactose-induced cataract in a rat model.
Sadik NAH, El-Boghdady NA, Omar NN, Al-Hamid HA.
J Food Biochem. 2020 Jul;44(7):e13230. doi: 10.1111/jfbc.13230. Epub 2020 Apr 16.
Histone acetyltransferase and Polo-like kinase 3 inhibitors prevent rat galactose-induced cataract.
Kanada F, Takamura Y, Miyake S, Kamata K, Inami M, Inatani M, Oki M.
Sci Rep. 2019 Dec 27;9(1):20085. doi: 10.1038/s41598-019-56414-x.
[Galactose cataract].
Akagi Y.
Nippon Ganka Gakkai Zasshi. 1992 Jan;96(1):1-2.
Riboflavin deficiency, galactose metabolism and cataract.
[No authors listed]
Nutr Rev. 1976 Mar;34(3):77-9. doi: 10.1111/j.1753-4887.1976.tb05706.x.
Histone acetyltransferase inhibition reverses opacity in rat galactose-induced cataract.
Nagaya M, Yamaoka R, Kanada F, Sawa T, Takashima M, Takamura Y, Inatani M, Oki M.
PLoS One. 2022 Nov 23;17(11):e0273868. doi: 10.1371/journal.pone.0273868. eCollection 2022.
Anti-Cataract Potential of Heliotropium indicum Linn on Galactose-Induced Cataract in Sprague-Dawley Rats.
Kyei S, Koffuor GA, Ramkissoon P, Abu EK, Sarpong JF.
Curr Eye Res. 2017 Mar;42(3):394-401. doi: 10.1080/02713683.2016.1198486. Epub 2016 Jul 15.
